This study is creating a collection of samples, called a biorepository, to help us better understand calciphylaxis. Calciphylaxis is a rare and serious condition where blood vessels in the skin harden. Currently, there isn't an effective treatment because we don't fully understand what causes it or the best ways to treat it. This biorepository aims to fill these knowledge gaps by collecting samples from patients. Researchers hope to learn more about the disease and identify factors that might improve calciphylaxis skin lesions. You may be able to join if you are 18 or older and have skin lesions consistent with calciphylaxis, as determined by your doctor. The study is looking to enroll 300 participants.

Study design

This is an observational study, meaning researchers will collect information and samples without giving any specific treatments. It aims to enroll 300 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will look for improvement in calciphylaxis skin lesions at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.